Promacta

Active Ingredient(s): Eltrombopag
FDA Approved: * November 20, 2008
Pharm Company: * GLAXOSMITHKLINE
Category: Blood Clotting (Hemostasis)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Promacta Overview

Eltrombopag is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts). It is a small molecule agonist of the c-mpl (TpoR) receptor, which is the physiological target of the hormone thrombopoietin. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Designated an orphan drug in the United States and European Union, it is being manufactured and marketed by Novarti...

Read more Promacta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eltrombopag

Recent Promacta Forums:

Home

Is Promacta a prescription drug or available over the counter? ## Promacta (eltrombopag) is available by prescription-only. You can view details about this drugs "prescribing information" in the link below: More over, other drug details can be viewed here: Please post back if you have any other general questions or concerns about this drug.

Updated October 31, 2011

1 REPLY SHARE RSS

Possible Dosages for this and Related Drugs:

Eltrombopag

For Suspension: Eq 25mg Acid/packet
Suspension: 25mg
Tablet: 12.5mg, 25mg, 50mg, 75mg, eq 100mg acid, eq 12.5mg acid, eq 25mg acid, eq 50mg acid, eq 75mg acid

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Promacta: (12 results)

Sorted by National Drug Code

0007-4640 Promacta 25 mg Oral Tablet by Glaxosmithkline LLC
0007-4641 Promacta 50 mg Oral Tablet by Glaxosmithkline LLC
0007-4642 Promacta 75 mg Oral Tablet by Glaxosmithkline LLC
0007-4643 Promacta 12.5 mg Oral Tablet by Glaxosmithkline LLC
0007-4644 Promacta 100 mg Oral Tablet by Glaxosmithkline LLC
0007-4646 Promacta 100 mg/1 Oral Tablet, Film Coated by Glaxosmithkline LLC
0078-0684 Promacta 12.5 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
0078-0685 Promacta 25 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
0078-0686 Promacta 50 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
0078-0687 Promacta 75 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
0078-0697 Promacta 25 mg Oral Powder, for Suspension by Novartis Pharmaceuticals Corporation
0078-0972 Promacta 12.5 mg Oral Powder, for Suspension by Novartis Pharmaceuticals Corporation

Other drugs which contain Eltrombopag or a similar ingredient: (1 result)

ELTROMBOPAG